High aspect ratio materials: Role of surface chemistry vs. length in the historical "long and short amosite asbestos fibers"

Inhalation Toxicology

Volumn 22, Issue 12, 2010, Pages 984-998

  Tomatis, Maura ^a   Turci, Francesco ^a   Ceschino, Raffaella ^a   Riganti, Chiara ^a,b   Gazzano, Elena ^a,b   Martra, Gianmario ^a   Ghigo, Dario ^a,b   Fubini, Bice ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Department of Genetics Biology and Biochemistry ^*  (Italy)

Author keywords

amosite; Asbestos; free radicals; iron mobilization; nitric oxide; surface properties

Indexed keywords

AMOSITE; ASBESTOS FIBER; ASCORBIC ACID; FREE RADICAL; IRON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HIGH ASPECT RATIO MATERIALS; HUMAN; HUMAN CELL; IRON KINETICS; MATERIALS; MICROMORPHOLOGY; OXIDATION; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; SURFACE PROPERTY;

ASBESTOS, AMOSITE; ASCORBIC ACID; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; ENZYME ACTIVATION; FREE RADICALS; HUMANS; IRON; NANOTECHNOLOGY; NITRIC OXIDE SYNTHASE; OXIDANTS; PARTICLE SIZE; PNEUMOCYTES; SPECTRUM ANALYSIS, RAMAN; SURFACE PROPERTIES;

EID: 77957586780     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2010.504243     Document Type: Article

References (81)

1. Adamson IY, Bowden DH. 1987a. Response of mouse lung to crocidolite asbestos. 2. Pulmonary fbrosis after long fbres. J Pathol 152:109-117.
2. Adamson IY, Bowden DH. 1987b. Response of mouse lung to crocidolite asbestos. 1. Minimal fbrotic reaction to short fbres. J Pathol 152:99-107.
3. Aldieri E, Ghigo D, Tomatis M, Prandi L, Fenoglio I, Costamagna C, Pescarmona G, Bosia A, Fubini B. 2001. Iron inhibits the nitric oxide synthesis elicited by asbestos in murine macrophages. Free Radic Biol Med 31:412-417.
4. Berlier G, Bonino F, Zecchina A, Bordiga S, Lamberti C. 2003. Anchoring Fe ions to amorphous and crystalline oxides: a means to tune the degree of Fe coordination. Chemphyschem 4:1073-1078.
5. Berman DW, Crump KS, Chatfeld EJ, Davis JM, Jones AD. 1995. Te sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal 15:181-195.
6. Berman DW, Crump KS. 2008a. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol 38 Suppl 1:1-47.
7. Berman DW, Crump KS. 2008b. A meta-analysis of asbestos-related cancer risk that addresses fber size and mineral type. Crit Rev Toxicol 38 Suppl 1:49-73.
8. Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. 2001. Biopersistence of synthetic mineral fbers as a predictor of chronic inhalation toxicity in rats. Inhal Toxicol 13:823-849. (Pubitemid 33020392)
9. Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. 2001. Biopersistence of synthetic mineral fbers as a predictor of chronic intraperitoneal injection tumor response in rats. Inhal Toxicol 13:851-875. (Pubitemid 33020393)
10. Blake T, Castranova V, Schwegler-Berry D, Baron P, Deye GJ, Li C, Jones W. 1998. Efect of fber length on glass microfber cytotoxicity. J Toxicol Environ Health Part A 54:243-259.
11. Boccuzzi F, Guglielminotti E, Pinna F Signoretto M. 1995. Surface-composition of Pd-Fe catalysts supported on silica. J Chem Soc Faraday Trans 1 91:3242
12. Brown RC, Carthew P, Hoskins JA, Sara E, Simpson CF. 1990. Surface modifcation can afect the carcinogenicity of asbestos. Carcinogenesis 11:1883-1885.
13. Brunauer S, Emmett PH, Teller E. 1938. Adsorption of gases in multimolecular layers. J Am Chem Soc 60:309-319.
14. Buettner GR, Oberley LW. 1978. Considerations in the spin trapping of superoxide and hydroxyl radical in aqueous systems using 5,5-dimethyl-1- pyrroline-1-oxide. Biochem Biophys Res Commun 83:69-74.
15. Chiappino G. 2004. Mesotelioma: il ruolo delle fbre ultrafni e conseguenti rifessi in campo preventivo e medico legale. Med Lav 96:3-23
16. Davis JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. 1986. Te pathogenicity of long versus short fbre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 67:415-430.
17. Descostes M, Mercier F, Tromat N, Beaucaire C, Gautier-Soyer M. 2000. Use of XPS in the determination of chemical environment and oxidation state of iron and sulfur samples: constitution of a data basis in binding energies for Fe and S reference compounds and applications to the evidence of surface species of an oxidized pyrite in a carbonate medium. Appl Surf Sci 165:288-302.
18. Dodson RF, Atkinson MA, Levin JL. 2003. Asbestos fber length as related to potential pathogenicity: a critical review. Am J Ind Med 44:291-297.
19. Dodson RF, Graef R, Shepherd S, O'Sullivan M, Levin J. 2005. Asbestos burden in cases of mesothelioma from individuals from various regions of the United States. Ultrastruct Pathol 29:415-433.
20. Dodson RF, Shepherd S, Levin J, Hammar SP 2007. Characteristics of asbestos concentration in lung as compared to asbestos concentration in various levels of lymph nodes that collect drainage from the lung. Ultrastruct Pathol 31:95-133.
21. Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi C. 1990. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis 142:843-847.
22. Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JM. 1989. Infammation generating potential of long and short fbre amosite asbestos samples. Br J Ind Med 46:271-276.
23. Donaldson K, Golyasnya N. 1994. Long and short amosite asbestos: comparison of chromosome-damaging eVects to cells in culture with in vivo pathology. In Cellular and molecular eVects of mineral and synthetic dusts and fbres, eds. JM Davis, MC Jaurand. pp. 221-226. Berlin.
24. Donaldson K, Li XY, Dogra S, Miller BG, Brown GM. 1992. Asbestos-stimulated tumour necrosis factor release from alveolar macrophages depends on fbre length and opsonization. J Pathol 168:243-248.
25. Donaldson K, Miller BG, Sara E, Slight J, Brown RC. 1993. Asbestos fbre lengthdependent detachment injury to alveolar epithelial cells in vitro: role of a fbronectin-binding receptor. Int J Exp Pathol 74:243-250.
26. Donaldson K, Tran CL. 2004. An introduction to the short-term toxicology of respirable industrial fbres. Mutat Res 553:5-9.
27. Elias Z, Poirot O, Danière MC, Terzetti F, Binet S, Tomatis M, Fubini B. 2002. Surface reactivity, cytotoxicity, and transforming potency of iron-covered compared to untreated refractory ceramic fbers. J Toxicol Environ Health Part A 65:2007-2027.
28. Fenoglio I, Fonsato S, Fubini B. 2003. Reaction of cysteine and glutathione (GSH) at the freshly fractured quartz surface: a possible role in silicarelated diseases? Free Radic Biol Med 35:752-762.
29. Fubini B. 1996. Use of physico-chemical and cell-free assays to evaluate the potential carcinogenicity of fbres. IARC Sci Publ 140:35-54.
30. Fubini B, Fenoglio I, Elias Z, Poirot O. 2001. Variability of biological responses to silicas: efect of origin, crystallinity, and state of surface on generation of reactive oxygen species and morphological transformation of mammalian cells. J Environ Pathol Toxicol Oncol 20 Suppl 1:95-108.
31. Fubini B, Mollo L, Giamello E. 1995. Free radical generation at the solid/liquid interface in iron containing minerals. Free Radic Res 23:593-614.
32. Fubini B, Otero AC 1999. Chemical aspects of the toxicity of inhaled mineral dusts. Chem. Soc. Rev 28:373-383.
33. Ghigo D, Aldieri E, Todde R, Costamagna C, Garbarino G, Pescarmona G, Bosia A. 1998. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest 102:595-605.
34. Gold J, Amandusson H, Krozer A, Kasemo B, Ericsson T, Zanetti G, Fubini B. 1997. Chemical characterization and reactivity of iron chelator-treated amphibole asbestos. Environ Health Perspect 105 Suppl 5:1021-1030.
35. Goodglick LA, Kane AB. 1990. Cytotoxicity of long and short crocidolite asbestos fbers in vitro and in vivo. Cancer Res 50:5153-5163.
36. Graham A, Higinbotham J, Allan D, Donaldson K, Beswick PH. 1999. Chemical diferences between long and short amosite asbestos: diferences in oxidation state and coordination sites of iron, detected by infrared spectroscopy. Occup Environ Med 56:606-611.
37. Hardy JA, Aust AE. 1995. Iron in asbestos chemistry and carcinogenicity. Chem Rev 95:97-111.
38. Hei TK, Xu A, Huang SX, Zhao Y. 2006. Mechanism of fber carcinogenesis: from reactive radical species to silencing of the beta igH3 gene. Inhal Toxicol 18:985-990.
39. Hesterberg TW, Miiller WC, Tevenaz P, Anderson R. 1995. Chronic inhalation studies of man-made vitreous fbres: characterization of fbres in the exposure aerosol and lungs. Ann Occup Hyg 39:637-653.
40. Hill IM, Beswick PH, Donaldson K. 1995. Diferential release of superoxide anions by macrophages treated with long and short fbre amosite asbestos is a consequence of diferential afnity for opsonin. Occup Environ Med 52:92-96.
41. Hochella MF. 1988. Auger electron and X-ray photoelectron spectroscopies. In Spectroscopic Methods in Mineralogy and Geology, Reviews in Mineralogy, eds. FC. Hawthorne, pp. 573-637.
42. Washington, DC Hochella MF. 1993. Surface chemistry, structure, and reactivity of hazardous mineral dust. Reviews in Mineralogy and Geochemistry 28:275-308
43. IARC. 2002. Monograph on the evaluation of carcinogenic risk to humans: manmade vitreous fbres, vol. 81. Lyon, France.
44. ILSI Report, Bernstein D, Castranova V Donaldson K, Fubini B, Hadley J, Hesterberg T, Kane A, Lai D, McConnell EE, Muhle H, Oberdorster G, Olin S, Warheit DB. 2005. Testing of fbrous particles: short-term assays and strategies. Inhal Toxicol 17:497-537.
45. Jaurand MC, Renier A, Daubriac J. 2009. Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol 6:16.
46. Kamp DW. 2009. Asbestos-induced lung diseases: an update. Transl Res 153:143-152.
47. Kamp DW, Weitzman SA. 1999. Te molecular basis of asbestos induced lung injury. Torax 54:638-652.
48. Kane AB. 1996. Mechanisms of mineral fbre carcinogenesis. IARC Sci Publ 140:11-34.
49. Kane AB, Hurt RH. 2008. Nanotoxicology: the asbestos analogy revisited. Nat Nanotechnol 3:378-379.
50. Lemaire I, Nadeau D, Dunnigan J, Massé S. 1985. An assessment of the fbrogenic potential of very short 4T30 chrysotile by intratracheal instillation in rats. Environ Res 36:314-326.
51. Lewis IR, Chafn NC, Gunter ME, Grifths PR. 1996. Vibrational spectroscopic studies of asbestos and comparison of suitability for remote analysis. Spectrochim Acta Part A 52:315-328.
52. Luys M-J, De Roy G, Vansant EF, Adams F. 1982. Characteristics of Asbestos Minerals. Structural Aspects and Infrared Spectra. J Chem Soc Faraday Trans 78:3561-3571.
53. Martra G, Chiardola E, Coluccia S, Marchese L, Tomatis M, Fubini B. 1999. Reactive sites at the surface of crocidolite asbestos. Langmuir 15:5742-5752.
54. Martra G, Tomatis M, Fenoglio I, Coluccia S, Fubini B. 2003. Ascorbic acid modifes the surface of asbestos: possible implications in the molecular mechanisms of toxicity. Chem Res Toxicol 16:328-335.
55. McDonald JC, Armstrong BG, Edwards CW, Gibbs AR, Lloyd HM, Pooley FD, Ross DJ, Rudd RM. 2001. Case-referent survey of young adults with mesothelioma: I. Lung fbre analyses. Ann Occup Hyg 45:513-518.
56. McIntyre NS, Davidson RD, Mycroft JR. 1996. Quantitative XPS measurements of some oxides, sulphides and complex minerals. Surf Interf Anal 24:591-596.
57. Muller J, Delos M, Panin N, Rabolli V Huaux F, Lison D. 2009. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat Toxicol Sci 110:442-448.
58. National Institute for Occupational Safety and Health (NIOSH), 2006. Criteria for A Recommended Standard, Occupational Exposure to Refractory Ceramic Fibers. Department of Health and Human Services, Centers for Disease Control Prevention, National Institute for Occupational Safety and Health, Atlanta, Georgia, pp 203
59. National Research Council (NRC), 2000. Review of the U.S. Navy's Exposure Standard for Manufactured Vitreous Fibers, Subcommittee on Manufactured Vitreous Fibers, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council. National Academy Press, Washington, DC
60. Occella E, Maddalon G. 1963. X-ray difraction characteristics of some types of asbestos in relation to diferent techniques of comminution. Med Lav 54:628-636.
61. Paoletti L, Falchi M, Batisti D, Zappa M, Chellini E, Biancalani M. 1993. Characterization of asbestos fbers in pleural tissue from 21 cases of mesothelioma. Med Lav 84:373-378.
62. Pezerat H, Zalma R, Guignard J, Jaurand MC. 1989. Production of oxygen radicals by the reduction of oxygen arising from the surface activity of mineral fbres. IARC Sci Publ 90:100-111.
63. Platek SF, Groth DH, Ulrich CE, Stettler LE, Finnell MS, Stoll M. 1985. Chronic inhalation of short asbestos fbers. Fundam Appl Toxicol 5: 327-340.
64. Plescia P, Gizzi D, Benedetti S, Camilucci L, Fanizza C, De Simone P, Paglietti F. 2003. Mechanochemical treatment to recycling asbestoscontaining waste. Waste Manag 23:209-218.
65. Poland CA, Dufn R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V Brown S, Macnee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423-428.
66. Riganti C, Aldieri E, Bergandi L, Tomatis M, Fenoglio I, Costamagna C, Fubini B, Bosia A, Ghigo D. 2003. Long and short fber amosite asbestos alters at a diferent extent the redox metabolism in human lung epithelial cells. Toxicol Appl Pharmacol 193:106-115.
67. Rinaudo C, Belluso E, Gastaldi D. 2004. Assessment of the use of Raman spectroscopy for the determination of amphibole asbestos. Mineral Mag 68:455-465.
68. Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW, Moss OR, Wong BA, Dodd DE, Andersen ME, Bonner JC. 2009. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 4:747-751.
69. Roggli VL. 2004. Asbestos Bodies and Nonasbestos Ferruginous Bodies. In Pathology of Asbestos-Associated Diseases, eds. VL Roggli, TD Oury, TA Sporn, pp. 34-70. Springer New York.
70. Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. 2009. Biopersistence and potential adverse health impacts of fbrous nanomaterials: what have we learned from asbestos? Wiley Interdiscip Rev Nanomed Nanobiotechnol 1, 511-529.
71. Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fbrous minerals. J Natl Cancer Inst 67:965-975.
72. Suzuki Y, Yuen SR. 2002. Asbestos fbers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci 982:160-176.
73. Suzuki Y, Yuen SR. 2001. Asbestos tissue burden study on human malignant mesothelioma. Ind Health 39:150-160.
74. Suzuki Y, Yuen SR, Ashley R. 2005. Short, thin asbestos fbers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health 208:201-210.
75. Tomatis M, Prandi L, Bodoardo S, Fubini B. 2002. Loss of surface reactivity upon heating amphibole asbestos. Langmuir 18:4345-4350.
76. Turci F, Favero-Longo SE, Tomatis M, Martra G, Castelli D, Piervittori R, Fubini B. 2007. A biomimetic approach to the chemical inactivation of chrysotile fbres by lichen metabolites. Chemistry 13:4081-4093.
77. Turci F, Tomatis M, Gazzano E, Riganti C, Martra G, Bosia A, Ghigo D, Fubini B. 2005. Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 2: Oxidant activity of the fbers. J Toxicol Environ Health Part A 68:21-39. (Pubitemid 40053260)
78. Werner AJ, Hochella MF Jr., Guthrie GD, Hardy JA, Aust AE, Rimstidt JD. 1995. Asbestoform riebeckite (crocidolite) dissolutions in the presence of Fe chelators: Implications for mineral-induced disease. Am Mineral 80:1093-1103.
79. WHO. Environmental health criteria: Asbestos and other natural mineral fbres. 1986. Geneva: World Health Organisation, vol 53.
80. Yuen S, Kubsh JE, Dumesic JA, Topsoee N, Topsoee H, Chen Y 2002. Metal oxide-support interactions in silica-supported iron oxide catalysts probed by nitric oxide adsorption. J Phys Chem 86:3022-3032.
81. Zeidler-Erdely PC, Calhoun WJ, Ameredes BT, Clark MP, Deye GJ, Baron P, Jones W, Blake T, Castranova V. 2006. In vitro cytotoxicity of Manville Code 100 glass fbers: efect of fber length on human alveolar macrophages. Part Fibre Toxicol 3:5.